PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Anaxon A.G., Brünnenstrasse 90, 3018, Bern, Switzerland.\', \'Dept. Anatomy, Animal Physiology & Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, 050095, Bucharest, Romania. Electronic address: bogdan@biologie.kappa.ro.\', \'CytoBioScience Inc., 3463 Magic Drive, San Antonio, TX, 78229, USA.\', \'Cytocentrics Bioscience GmbH, Nattermannallee 1, 50829, Cologne, Germany.\', \'Dept. Cardiovascular Sciences, Faculty of Medicine, K U Leuven, B-3000, Leuven, Belgium; Dept. Basic Sciences, Faculty of Medicine, Université Catholique de Bukavu, Bukavu, DR Congo.\', \'Dept. Anatomy, Animal Physiology & Biophysics, Faculty of Biology, University of Bucharest, Splaiul Independentei 91-95, 050095, Bucharest, Romania.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0014-2999(21)00788-310.1016/j.ejphar.2021.174632
?:hasPublicationType
?:journal
  • European journal of pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34785211
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.057
?:rankingScore_hIndex
  • 161
is ?:relation_isRelatedTo_publication of
?:title
  • Assessment of proarrhythmogenic risk for chloroquine and hydroxychloroquine using the CiPA concept.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all